Lars Bullinger
Impact in
- Hematology top 0.02%
- Acute Myeloid Leukemia Research
- Genetics top 0.05%
- Chronic Lymphocytic Leukemia Research
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 187
- Acute Myeloid Leukemia Research 157
- Chronic Myeloid Leukemia Treatments 36
-
- Protein Degradation and Inhibitors 35
- Epigenetics and DNA Methylation 30
- Co-authors
- Hartmut Döhner (113 shared papers)Konstanze Döhner (106 shared papers)Stephan Stilgenbauer (24 shared papers)Axel Benner (24 shared papers)Richard F. Schlenk (57 shared papers)Peter Lichter (15 shared papers)Alexander Kröber (4 shared papers)Stefan Fröhling (30 shared papers)
- Journals
- Blood (96 papers)Leukemia (30 papers)Haematologica (15 papers)Journal of Clinical Oncology (12 papers)Oncotarget (7 papers)
- Partner nations
- GermanyUnited StatesUnited Kingdom
In The Last Decade
Lars Bullinger
310 papers receiving 16.6k citations
Lars Bullinger's Hit Papers
Peers
Comparison fields: 5 of 145
- Hematology 7.3k
- Genetics 5.3k
- Pathology and Forensic Medicine 2.8k
- Cancer Research 2.3k
- Immunology 2.6k
Countries citing papers authored by Lars Bullinger
This map shows the geographic impact of Lars Bullinger's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lars Bullinger with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lars Bullinger more than expected).
Fields of papers citing papers by Lars Bullinger
This network shows the impact of papers produced by Lars Bullinger. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lars Bullinger. The network helps show where Lars Bullinger may publish in the future.
Co-authors
The 25 scholars most cited alongside Lars Bullinger, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 329 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Genomic Aberrations and Survival in Chronic Lymphocytic Leukemia Hit paper breakdown → | 2000 | 2269 |
| 2 | Mutations and Treatment Outcome in Cytogenetically Normal Acute Myeloid Leukemia Hit paper breakdown → | 2008 | 1112 |
| 3 | Use of Gene-Expression Profiling to Identify Prognostic Subclasses in Adult Acute Myeloid Leukemia Hit paper breakdown → | 2004 | 705 |
| 4 | MLL-Rearranged Leukemia Is Dependent on Aberrant H3K79 Methylation by DOT1L Hit paper breakdown → | 2011 | 646 |
| 5 | Mutant nucleophosmin (NPM1) predicts favorable prognosis in younger adults with acute myeloid leukemia and normal cytogenetics: interaction with other gene mutations Hit paper breakdown → | 2005 | 608 |
| 6 | V H mutation status, CD38 expression level, genomic aberrations, and survival in chronic lymphocytic leukemia Hit paper breakdown → | 2002 | 597 |
| 7 | IDH1andIDH2Mutations Are Frequent Genetic Alterations in Acute Myeloid Leukemia and Confer Adverse Prognosis in Cytogenetically Normal Acute Myeloid Leukemia WithNPM1Mutation WithoutFLT3Internal Tandem Duplication Hit paper breakdown → | 2010 | 581 |
| 8 | 2009 | 420 | |
| 9 | Genomics of Acute Myeloid Leukemia Diagnosis and Pathways Hit paper breakdown → | 2017 | 339 |
| 10 | 2011 | 333 | |
| 11 | 2008 | 330 | |
| 12 | 2010 | 270 | |
| 13 | 2010 | 265 | |
| 14 | 2011 | 218 | |
| 15 | 2012 | 212 | |
| 16 | 2002 | 192 | |
| 17 | 2015 | 189 | |
| 18 | 2013 | 182 | |
| 19 | 2012 | 171 | |
| 20 | 2017 | 163 |
About Lars Bullinger
Lars Bullinger is a scholar working on Hematology, Molecular Biology, Genetics, Oncology and Cancer Research, having authored 329 papers that have together received 16.9k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (157 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (36 papers), Chronic Myeloid Leukemia Treatments (36 papers), Protein Degradation and Inhibitors (35 papers), Chronic Lymphocytic Leukemia Research (31 papers), Epigenetics and DNA Methylation (30 papers), Cancer Genomics and Diagnostics (22 papers) and CAR-T cell therapy research (21 papers). The work is most often cited by research in Hematology (7.3k citations), Genetics (5.3k citations), Pathology and Forensic Medicine (2.8k citations), Cancer Research (2.3k citations) and Immunology (2.6k citations). Lars Bullinger has collaborated with scholars based in Germany, United States and United Kingdom. Frequent co-authors include Hartmut Döhner, Konstanze Döhner, Stephan Stilgenbauer, Axel Benner, Richard F. Schlenk, Peter Lichter, Alexander Kröber, Stefan Fröhling, Martin Bentz and Elke Leupolt. Their work appears in journals such as Blood, Leukemia, Haematologica, Journal of Clinical Oncology and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.